cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Neximmune Inc
6 own
9 watching
Current Price
$3.61
$-0.33
(-8.38%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
2.27M
52-Week High
52-Week High
28.69500
52-Week Low
52-Week Low
0.15000
Average Volume
Average Volume
0.02M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization2.27M
icon52-Week High28.69500
icon52-Week Low0.15000
iconAverage Volume0.02M
iconDividend Yield--
iconP/E Ratio--
What does the Neximmune Inc do?
NexImmune, Inc., a clinical-stage biotechnology company, engages in developing therapies with curative potential for patients with cancer and other life-threatening immune-mediated diseases. It develops approaches to T cell immunotherapies based on its proprietary Artificial Immune Modulation, a nanoparticle technology platform. The company s product candidates include NEXI-001, an allogeneic cell therapy, which is in Phase I/II clinical trials for the treatment of patients with acute myeloid leukemia; NEXI-002, an autologous cell therapy that is in Phase I/II clinical trials for the treatment of patients with relapsed and/or refractory in multiple myeloma; and NEXI-003, a candidate targeted against HPV-associated malignancies, which is in preclinical stage. NexImmune, Inc. was incorporated in 2011 and is headquartered in Gaithersburg, Maryland.
Read More
How much money does Neximmune Inc make?
News & Events about Neximmune Inc.
PR Newswire
1 year ago
Thinking about buying stock in Neximmune, Inozyme Pharma, Shopify, AMC Entertainment, or ContextLogic? Thinking about buying stock in Neximmune, Inozyme Pharma, Shopify, AMC Entertainment, or ContextLogic? PR Newswire NEW YORK, Feb. 16, 2023 NEW YORK, Feb. 16, 2023 /PRNewswire...
PR Newswire
1 year ago
Thinking about buying stock in Neximmune, ShiftPixy, IN8BIO, Relay Therapeutics, or Reata Pharmaceuticals? Thinking about buying stock in Neximmune, ShiftPixy, IN8BIO, Relay Therapeutics, or Reata Pharmaceuticals? PR Newswire NEW YORK, Sept. 8, 2022 NEW YORK, Sept. 8, 2022 /PRNewswire...
PR Newswire
1 year ago
Thinking about buying stock in Allogene Therapeutics, Neximmune, Vertical Aerospace, Sonim Technologies, or DigitalBridge? Thinking about buying stock in Allogene Therapeutics, Neximmune, Vertical Aerospace, Sonim Technologies, or DigitalBridge? PR Newswire NEW YORK, July 15, 2022 NEW YORK, July...
Benzinga
2years ago
The Dow Jones jumped around 200 points on Tuesday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor...
Benzinga
2years ago
read more...
Frequently Asked Questions
Frequently Asked Questions
What is Neximmune Inc share price today?
plus_minus_icon
Can Indians buy Neximmune Inc shares?
plus_minus_icon
How can I buy Neximmune Inc shares from India?
plus_minus_icon
Can Fractional shares of Neximmune Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Neximmune Inc stocks?
plus_minus_icon
What is today’s traded volume of Neximmune Inc?
plus_minus_icon
What is today’s market capitalisation of Neximmune Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Neximmune Inc?
plus_minus_icon
What percentage is Neximmune Inc down from its 52-Week High?
plus_minus_icon
What percentage is Neximmune Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$3.61
$-0.33
(-8.38%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00